Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Compass Therapeutics
Exelixis
Neomorph, Inc
Bristol-Myers Squibb
City of Hope Medical Center
Xencor, Inc.
Novartis
AstraZeneca
Jonsson Comprehensive Cancer Center
ViroMissile, Inc.
Arcus Biosciences, Inc.
Arcus Biosciences, Inc.
City of Hope Medical Center
Pfizer
Tizona Therapeutics, Inc
Novartis
Genentech, Inc.
Shanghai Henlius Biotech
Canadian Cancer Trials Group
Deciphera Pharmaceuticals, LLC
Incyte Corporation
Poseida Therapeutics, Inc.
Werewolf Therapeutics, Inc.
St. Jude Children's Research Hospital
MacroGenics
City of Hope Medical Center
Novartis
SAPU NANO (US) LLC
HiberCell, Inc.
M.D. Anderson Cancer Center
Philogen S.p.A.
National Institutes of Health Clinical Center (CC)
Novartis
Bayer
Kura Oncology, Inc.
City of Hope Medical Center
Calico Life Sciences LLC